Select Publications

Book Chapters

Graf L; Webel R; Wagner S; Hamilton S; Rawlinson W; Stitch H; Marschall M, 2014, 'The Cyclin-dependent kinase ortholog pUL97 of human cytomegalovirus interacts with cyclins', in Recent CMV Research

Journal articles

Singh K; Hamilton ST; Shand AW; Hannan NJ; Rawlinson WD, 2021, 'Receptors in host pathogen interactions between human cytomegalovirus and the placenta during congenital infection', Reviews in Medical Virology, vol. 31, http://dx.doi.org/10.1002/rmv.2233

Hamilton ST; Hahn F; Sonntag E; Marschall M; Rawlinson WD, 2021, 'A placental specific miRNA miR-517a-3p exerts anti-human cytomegalovirus activity', Placenta, vol. 112, pp. 62 - 65, http://dx.doi.org/10.1016/j.placenta.2021.06.013

Hamilton ST; Marschall M; Rawlinson WD, 2021, 'Investigational antiviral therapy models for the prevention and treatment of congenital cytomegalovirus infection during pregnancy', Antimicrobial Agents and Chemotherapy, vol. 65, http://dx.doi.org/10.1128/AAC.01627-20

Naing Z; Hamilton ST; van Zuylen WJ; Scott GM; Rawlinson WD, 2020, 'Differential Expression of PDGF Receptor-α in Human Placental Trophoblasts Leads to Different Entry Pathways by Human Cytomegalovirus Strains', Scientific Reports, vol. 10, http://dx.doi.org/10.1038/s41598-020-57471-3

Bartlett AW; Hamilton ST; Shand AW; Rawlinson WD, 2020, 'Fetal therapies for cytomegalovirus: What we tell prospective parents', Prenatal Diagnosis, vol. 40, pp. 1681 - 1692, http://dx.doi.org/10.1002/pd.5692

Häge S; Horsch D; Stilp AC; Kicuntod J; Müller R; Hamilton ST; Egilmezer E; Rawlinson WD; Stamminger T; Sonntag E; Marschall M, 2020, 'A quantitative nuclear egress assay to investigate the nucleocytoplasmic capsid release of human cytomegalovirus', Journal of Virological Methods, vol. 283, http://dx.doi.org/10.1016/j.jviromet.2020.113909

Singh K; Palasanthiran P; Hamilton ST; Rawlinson WD, 2020, 'Cotton wool balls are an effective urine collection tool for CMV PCR for diagnosing congenital cytomegalovirus infection', Pathology, vol. 52, pp. 504 - 506, http://dx.doi.org/10.1016/j.pathol.2020.03.009

Helbig KJ; Bull RA; Ambrose R; Beard MR; Blanchard H; Böcking T; Chua B; Colmant AMG; Crosse KM; Purcell DFJ; Fraser J; Hayward JA; Hamilton ST; Husain M; MacDiarmid R; MacKenzie JM; Moseley GW; Nguyen THO; Quiñones-Mateu ME; Robinson K; Rodrigo C; Rodriguez-Andres J; Rudd PA; Werno A; White P; Young P; Speck P; Hibma M; Drummer HE; Tachedjian G, 2020, 'Tenth scientific biennial meeting of the australasian virology society - AVS10 2019', Viruses, vol. 12, http://dx.doi.org/10.3390/v12060621

Wong DD; Van Zuylen WJ; Hamilton ST; Steingruber M; Sonntag E; Marschall M; Rawlinson WD, 2019, 'Patient-derived cytomegaloviruses with different ganciclovir sensitivities from UL97 mutation retain their replication efficiency and some kinase activity in vitro', Antimicrobial Agents and Chemotherapy, vol. 63, http://dx.doi.org/10.1128/AAC.02425-18

Hamilton ST; Hutterer C; Egilmezer E; Steingruber M; Milbradt J; Marschall M; Rawlinson WD, 2018, 'Human cytomegalovirus utilises cellular dual-specificity tyrosine phosphorylation-regulated kinases during placental replication', Placenta, vol. 72-73, pp. 10 - 19, http://dx.doi.org/10.1016/j.placenta.2018.10.002

Hahn F; Hutterer C; Henry C; Hamilton ST; Strojan H; Kraut A; Schulte U; Schütz M; Kohrt S; Wangen C; Pfizer J; Couté Y; Rawlinson WD; Strobl S; Marschall M, 2018, 'Novel cytomegalovirus-inhibitory compounds of the class pyrrolopyridines show a complex pattern of target binding that suggests an unusual mechanism of antiviral activity', Antiviral Research, vol. 159, pp. 84 - 94, http://dx.doi.org/10.1016/j.antiviral.2018.09.012

Hutterer C; Milbradt J; Hamilton S; Zaja M; Leban J; Henry C; Vitt D; Steingruber M; Sonntag E; Zeitträger I; Bahsi H; Stamminger T; Rawlinson W; Strobl S; Marschall M, 2017, 'Inhibitors of dual-specificity tyrosine phosphorylation-regulated kinases (DYRK) exert a strong anti-herpesviral activity', Antiviral Research, vol. 143, pp. 113 - 121, http://dx.doi.org/10.1016/j.antiviral.2017.04.003

van Zuylen WJ; Zheng QY; Hamilton ST; Egilmezer EE; Craig ME; Gralton J; Rawlinson WD, 2017, 'Prevalence of cytomegalovirus carriage among childcare staff', Journal of Paediatrics and Child Health, vol. 53, pp. 724, http://dx.doi.org/10.1111/jpc.13600

Rawlinson WD; Boppana SB; Fowler KB; Kimberlin DW; Lazzarotto T; Alain S; Daly K; Doutré S; Gibson L; Giles ML; Greenlee J; Hamilton ST; Harrison GJ; Hui L; Jones CA; Palasanthiran P; Schleiss MR; Shand AW; van Zuylen WJ, 2017, 'Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy', The Lancet Infectious Diseases, vol. 17, pp. e177 - e188, http://dx.doi.org/10.1016/S1473-3099(17)30143-3

Ornelas AMM; Pezzuto P; Silveira PP; Melo FO; Ferreira TA; Oliveira-Szejnfeld PS; Leal JI; Amorim MMR; Hamilton S; Rawlinson WD; Cardoso CC; Nixon DF; Tanuri A; Melo AS; Aguiar RS, 2017, 'Immune activation in amniotic fluid from Zika virus–associated microcephaly', Annals of Neurology, vol. 81, pp. 152 - 156, http://dx.doi.org/10.1002/ana.24839

Rawlinson WD; Hamilton ST; Van Zuylen WJ, 2016, 'Update on treatment of cytomegalovirus infection in pregnancy and of the newborn with congenital cytomegalovirus', Current Opinion in Infectious Diseases, vol. 29, pp. 615 - 624, http://dx.doi.org/10.1097/QCO.0000000000000317

Hutterer C; Hamilton S; Steingruber M; Zeitträger I; Bahsi H; Thuma N; Naing Z; Örfi Z; Örfi L; Socher E; Sticht H; Rawlinson W; Chou S; Haupt VJ; Marschall M, 2016, 'The chemical class of quinazoline compounds provides a core structure for the design of anticytomegaloviral kinase inhibitors', Antiviral Research, vol. 134, pp. 130 - 143, http://dx.doi.org/10.1016/j.antiviral.2016.08.005

Sonntag E; Hamilton ST; Bahsi H; Wagner S; Jonjic S; Rawlinson WD; Marschall M; Milbradt J, 2016, 'Cytomegalovirus pUL50 is the multi-interacting determinant of the core nuclear egress complex (NEC) that recruits cellular accessory NEC components', Journal of General Virology, vol. 97, pp. 1676 - 1685, http://dx.doi.org/10.1099/jgv.0.000495

Naing ZW; Scott GM; Shand A; Hamilton ST; Van Zuylen WJ; Basha J; Hall B; Craig ME; Rawlinson WD, 2016, 'Congenital cytomegalovirus infection in pregnancy: A review of prevalence, clinical features, diagnosis and prevention', Australian and New Zealand Journal of Obstetrics and Gynaecology, vol. 56, pp. 9 - 18, http://dx.doi.org/10.1111/ajo.12408

Graf L; Feichtinger S; Naing Z; Hutterer C; Milbradt J; Webel R; Wagner S; Scott GM; Hamilton ST; Rawlinson WD; Stamminger T; Thomas M; Marschall M, 2016, 'New insight into the phosphorylation-regulated intranuclear localization of human cytomegalovirus pUL69 mediated by cyclin-dependent kinases (CDKs) and viral CDK orthologue pUL97', Journal of General Virology, vol. 97, pp. 144 - 151, http://dx.doi.org/10.1099/jgv.0.000337

Sonntag E; Hamilton ST; Bahsi H; Wagner S; Jonjic S; Rawlinson WD; Marschall M; Milbradt J, 2016, 'Erratum to Cytomegalovirus pUL50 is the multi-interacting determinant of the core nuclear egress complex (NEC) that recruits cellular accessory NEC components.', J Gen Virol, vol. 97, pp. 2461, http://dx.doi.org/10.1099/jgv.0.000599

Hamilton ST; Hutterer C; Marschall M, 2015, 'Therapeutics to prevent congenital cytomegalovirus during pregnancy: what is available now and in the future?', MICROBIOLOGY AUSTRALIA, vol. 36, pp. 156 - 161, http://dx.doi.org/10.1071/MA15057

Naing ZW; Scott GM; Shand A; Hamilton ST; van Zuijlen WJ; Basha J; Hall B; Craig ME; Rawlinson WD, 2015, 'Congenital cytomegalovirus infection in pregnancy: a review of prevalence, clinical features, diagnosis and prevention', Aust N Z J Obstet Gynaecol., http://dx.doi.org/10.1111/ajo.12408

Naing Z; Webel R; Hamilton S; Schmeiser C; Scott G; Marschall M; Rawlinson WD, 2015, 'Stimulatory effects of human cytomegalovirus tegument protein pp71 lead to increased expression of CCL2 (monocyte chemotactic protein-1) during infection', Journal of General Virology, vol. 96, pp. 1855 - 1862, http://dx.doi.org/10.1099/vir.0.000101

Rogers N, 2015, 'A dormant danger: New therapies target a ubiquitous pathogen known as cytomegalovirus.', Nat Med, vol. 21, pp. 1104 - 1105, http://dx.doi.org/10.1038/nm1015-1104

Hamilton ST; van Zuylen W; Shand A; Naing Z; Hall B; Craig ME; Rawlinson W, 2014, 'Prevention of Congenital Cytomegalovirus by Maternal and Neonatal Treatments: A Systematic Review', Medical Virology, vol. 24, pp. 420 - 433, http://dx.doi.org/10.1002/rmv.1814

van Zuylen WJ; Hamilton ST; Naing Z; Hall B; Shand A; Rawlinson W, 2014, 'Congenital Cytomegalovirus Infection: Epidemiology, Diagnosis and Prevention', Obstetric Medicine: The Medicine of Pregnancy, vol. 7, pp. 140 - 146, http://dx.doi.org/10.1177/1753495X14552719

Hamilton ST; Milbradt J; Marschall M; Rawlinson WD, 2014, 'Human cytomegalovirus replication is strictly inhibited by siRNAs targeting UL54, UL97 or UL122/123 gene transcripts', PLoS ONE, vol. 9, http://dx.doi.org/10.1371/journal.pone.0097231

Milbradt J; Kraut A; Hutterer C; Sonntag E; Schmeiser C; Ferro M; Wagner S; Lenac T; Claus C; Pinkert S; Hamilton ST; Rawlinson WD; Sticht H; Couté Y; Marschall M, 2014, 'Proteomic analysis of the multimeric nuclear egress complex of human cytomegalovirus', Molecular and Cellular Proteomics, vol. 13, pp. 2132 - 2146, http://dx.doi.org/10.1074/mcp.M113.035782

Graf L; Webel R; Wagner S; Hamilton ST; Rawlinson WD; Sticht H; Marschall M, 2013, 'The cyclin-dependent kinase ortholog pUL97 of human cytomegalovirus interacts with cyclins', Viruses, vol. 5, pp. 3213 - 3230, http://dx.doi.org/10.3390/v5123213

Hamilton ST; Scott GM; Naing Z; Rawlinson WD, 2013, 'Human cytomegalovirus directly modulates expression of chemokine CCL2 (MCP-1) during viral replication', Journal of General Virology, vol. 94, pp. 2495 - 2503, http://dx.doi.org/10.1099/vir.0.052878-0

Hamilton ST; Scott GMS; Naing ZW; Iwasenko JM; Hall B; Graf NS; Arbuckle SM; Craig ME; Rawlinson WD, 2012, 'Human cytomegalovirus induces cytokine changes in the placenta with implications for adverse pregnancy outcomes', PLoS ONE, vol. 7, pp. e52899, http://dx.doi.org/10.1371/journal.pone.0052899

Conference Papers

Hamilton S, 2010, 'The Role of Human Cytomegalovirus in Stillbirth and Other Adverse Outcomes of Pregnancy', Sydney, presented at ISA and ISPID Joint Conference, Sydney, 08 October 2010 - 10 October 2010

Conference Abstracts

Hamilton S, 2019, 'Therapeutics for the prevention of congenital cytomegalovirus infection and disease during pregnancy.', in The 10th Biennial Meeting of the Australasian Virology Society Handbook, presented at 10th Australasian Virology Society (AVS10) Meeting. Queenstown, New Zealand

Hamilton S, 2018, 'Human cytomegalovirus utilises cellular dual-specificity tyrosine phosphorylation-regulated kinases during placental replication', in 43rd Annual International Herpes Virus Workshop Handbook, presented at 43rd Annual International Herpes Virus Workshop. Vancouver, Canada

Hamilton S, 2017, 'Novel Antivirals for the Prevention and Treatment of Congenital CMV', in Conference Handbook, Amsterdam, Netherlands, presented at The 16th International CMV/Betaherpesvirus Workshop and 6th International Congenital CMV Conference Combined Meeting. Amsterdam, Netherlands, Amsterdam, Netherlands, 30 April 2017 - 04 May 2017

Hamilton S, 2012, 'Small Interfering RNA (siRNA) Molecules as a Novel Therapeutic Strategy in the Prevention of Congenital CMV', in Conference Handbook, San Francisco, USA, presented at The 14th International CMV/Betaherpesvirus Workshop and 4th International Congenital CMV Conference Combined Meeting., San Francisco, USA, 29 October 2012 - 02 November 2012

Hamilton S, 2011, 'CMV-induced Cytokine Changes within the Placenta and the Implications for Pregnancy Outcome.', in Conference Handbook, Nuremberg, Germany, presented at The 13th International CMV/Betaherpesvirus Workshop., Nuremberg, Germany, 14 May 2011 - 17 May 2011


Back to profile page